RE:RE:RE:with this FDA ok, we can sell that riplazym voucher It's difficult to understand if the horrible management is intentional to justify tanking all of the molecules or if management really are this bad? Either way, it's embarrassing to see for something Boehringher was at the table with PLI on a handshake deal for $1B with all upfront and milestones, royalties for a small molecule.
wyndewest wrote: 'No Vision. No management plan.' That is the understatement of the year!!! This company is going nowhere but down, down, down...